Laman UtamaTEL1 • FRA
add
Sihuan Pharmaceutical Holdings Group Ltd
Tutup sebelumnya
€0.15
Julat hari
€0.14 - €0.14
Julat tahun
€0.065 - €0.21
Permodalan pasaran
12.16B HKD
Bilangan Purata
67.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
HKG
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 735.90J | 54.70% |
Perbelanjaan pengendalian | 386.99J | -22.90% |
Pendapatan bersih | 38.55J | 142.07% |
Margin untung bersih | 5.24 | 127.21% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 185.33J | 232.48% |
Kadar cukai berkesan | 54.19% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.98B | 9.48% |
Jumlah aset | 11.63B | 10.45% |
Jumlah liabiliti | 4.73B | -15.24% |
Jumlah ekuiti | 6.90B | — |
Syer tertunggak | 9.04B | — |
Harga kepada buku | 0.23 | — |
Pulangan pada aset | 2.91% | — |
Pulangan pada modal | 4.30% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 38.55J | 142.07% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
CEO
Diasaskan
2001
Tapak web
Pekerja
2,843
